EyePoint Plc (EYPT)
14.72
+0.36
(+2.51%)
USD |
NASDAQ |
Feb 19, 16:00
14.68
-0.04
(-0.24%)
After-Hours: 20:00
EyePoint EPS Diluted (Quarterly) : -0.8513 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | -1.852 |
| Viking Therapeutics, Inc. | -1.383 |
| Tango Therapeutics, Inc. | 0.1431 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -59.73M |
| Revenue (Quarterly) | 0.966M |
| Total Expenses (Quarterly) | 60.70M |
| Enterprise Value | 1.038B |
| Gross Profit Margin (Quarterly) | 25.36% |
| Profit Margin (Quarterly) | -6.18K% |
| Earnings Yield | -20.31% |
| Normalized Earnings Yield | -20.31 |